跳至主要内容
临床试验/NCT07253454
NCT07253454尚未招募不适用

Combined Use of Machine Learning and Metabolomics to Improve the Diagnosis and Management of Hyperandrogenism

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 800 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
800
主要终点
Use of machine learning models combined with metabolomics to distinguish between different causes of hyperandrogenism

研究概览

简要总结

Hyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of androgens usually manifests clinically as increased male-pattern hair growth and, less specifically, acne and alopecia. Its prevalence is estimated at between 6 and 12% in women of reproductive age, and its incidence is increasing.

It is also responsible for infertility. As a reminder, infertility is a major public health issue and affects more and more couples around the world.

The investigators therefore wish to develop innovative tools to improve the diagnosis and management of hyperandrogenism

详细描述

Hyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of androgens usually manifests clinically as increased male-pattern hair growth and, less specifically, acne and alopecia. Its prevalence is estimated at between 6 and 12% in women of reproductive age, and its incidence is increasing.

It is also responsible for infertility. As a reminder, infertility is a major public health issue and affects more and more couples around the world.

The investigators therefore wish to develop innovative tools to improve the diagnosis and management of hyperandrogenism

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients of childbearing age (16 to 45 years old)
  • Suffering from hyperandrogenism
  • Established etiological diagnosis with elimination of differential diagnoses
  • Informed and not opposed to the collection of their data for the purposes of the study

排除标准

  • Pregnancy
  • Patients under legal protection measures

结局指标

主要结局

Use of machine learning models combined with metabolomics to distinguish between different causes of hyperandrogenism

时间窗: 5 years

次要结局

  • Use of metabolomics to improve the management of patients with hyperandrogenism(5 years)
  • Use of metabolomics to predict CYP21A2 genotyping results(5 years)
  • Study of the impact of anti-androgenic hormone therapy on the predictive capabilities of the model(5 years)

研究者

申办方类型
Other
责任方
Sponsor

相似试验